NEW YORK, March 23 (Reuters) - Mylan Laboratories Inc. said on Friday it launched generic versions of Pfizer Inc.'s blockbuster Norvasc blood-pressure drug, a day after a federal court ruled a Pfizer ...
NEW YORK, March 22 (Reuters) - A U.S. appeals court on Thursday reversed a lower court patent decision that had favored Pfizer Inc. in its bid to prevent Canadian drugmaker Apotex Inc. from launching ...
Senators Question Pfizer, Mylan and Three Other Companies Over Opioid Overdose Treatment Price Hikes
Sens. Susan Collins (R-ME) and Claire McCaskill (D-MO) sent five identical letters late last week to opioid overdose antidote manufacturers Pfizer, Amphastar Pharmaceuticals, Mylan, Kaléo Pharma and ...
The US Food and Drug Administration (FDA) recently issued a safety alert to inform that EpiPen manufacturer, Pfizer, has become aware that the label sticker on certain auto-injectors “may have been ...
In separate consent judgments, Pfizer Inc. and Mylan Specialty LP will be required to submit new ad campaigns for EpiPen, a mobile device used to treat acute allergic reactions. Pfizer and Mylan must ...
NEW YORK--(BUSINESS WIRE)--Nussbaum Law Group, P.C. and Roberts Law Firm US, PC: A proposed settlement (“Settlement”) has been reached in a class action lawsuit alleging that Mylan N.V., Mylan ...
INDIANAPOLIS — The state of Indiana is suing two of the world's biggest drug companies over the price of EpiPens. Attorney General Todd Rokita claims that Mylan and Pfizer have conspired to increase ...
PITTSBURGH — Generic drug maker Mylan has settled a patent litigation suit with Pfizer concerning a drug for treating bladder disorders, Mylan said Friday. The Pittsburgh-based company said it settled ...
The proposed settlement, which requires a judge’s approval, would resolve a legal battle that began after the company, in 2016, raised the price for two EpiPens to $608 from $100. By Jesus Jiménez The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results